Association of body mass index with arrhythmia progression and outcomes in patients with subclinical atrial fibrillation: insights from the ARTESiA trial

12 April 2026 (16:30 - 17:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Mate Vamos

University of Szeged, Szeged (Hungary)

4 More presentations in this session

Presentation thumbnail

Risk of stroke in hemodialysis patients with new-onset atrial fibrillation

Associate Professor L. Jung (Jeonju, KR)

Abstract Slides Video

Presentation thumbnail

Association of estimated glomerular filtration rate differences with brain lesions in patients with atrial fibrillation

Mr M. Mutti (Basel, CH)

Abstract Slides Video

Presentation thumbnail

Microbleeds in patients with heart failure and atrial fibrillation

Doctor B. Voegeli (Basel, CH)

Abstract Slides Video

Presentation thumbnail

AI-based individual risk prediction of oral anticoagulation in patients with cirrhosis and atrial fibrillation

Associate Professor I. Kim (Seoul, KR)

Abstract Slides Video

Access the full session

Session thumbnail

Stroke in atrial fibrillation (1)

The Event

Event poster

EHRA 2026

12 April 2026 16:30 CET

You may be interested in

Congress Presentation

Ablation outcome and post-interventional management of anticoagulation in patients with obesity or severe obesity and atrial fibrillation

Congress Presentation

Impact of differences in body mass index, body surface area and lean body mass on clinical outcomes in patients with atrial fibrillation receiving edoxaban: 4-year follow-up data from ETNA-AF-Europe

Congress Presentation

Impact of body weight and body mass index on clinical outcomes of edoxaban therapy in atrial fibrillation patients included in the ETNA-AF-Global registry

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources